The Polymerase Chain Reaction was developed in 1983, and since that time it's become one of the most commonly-used techniques in labs across the world. The ability to amplify one region of DNA using ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), provides an overview of advances supporting the Company’s overall corporate strategy to improve science and healthcare in the year to date. Centered ...

Bio-Rad Laboratories has received FDA clearance for two digital PCR products designed to monitor patients’ molecular responses to tyrosine kinase inhibitor treatments in chronic myeloid leukemia. The ...

HERCULES, CA--(Marketwired - February 25, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) today announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...

Bio-Rad will be launching two new real-time PCR detection tools to be used for in-vitro diagnostic testing. Bio-Rad Laboratories, a life science research and clinical diagnostics product provider, ...

A new procedure can improve polymerase chain reaction (PCR)-based methods of detecting plant disease organisms. A new procedure devised by U.S. Department of Agriculture (USDA) scientists and ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...

Anyone who has worked with DNA in the lab is probably (all too) familiar with a very special reaction, the polymerase chain reaction, or PCR. The technique allows one to make an enormous number of ...